Comparative analysis of the end-joining activity of several DNA ligases

PLoS One. 2017 Dec 28;12(12):e0190062. doi: 10.1371/journal.pone.0190062. eCollection 2017.

Abstract

DNA ligases catalyze the repair of phosphate backbone breaks in DNA, acting with highest activity on breaks in one strand of duplex DNA. Some DNA ligases have also been observed to ligate two DNA fragments with short complementary overhangs or blunt-ended termini. In this study, several wild-type DNA ligases (phage T3, T4, and T7 DNA ligases, Paramecium bursaria chlorella virus 1 (PBCV1) DNA ligase, human DNA ligase 3, and Escherichia coli DNA ligase) were tested for their ability to ligate DNA fragments with several difficult to ligate end structures (blunt-ended termini, 3'- and 5'- single base overhangs, and 5'-two base overhangs). This analysis revealed that T4 DNA ligase, the most common enzyme utilized for in vitro ligation, had its greatest activity on blunt- and 2-base overhangs, and poorest on 5'-single base overhangs. Other ligases had different substrate specificity: T3 DNA ligase ligated only blunt ends well; PBCV1 DNA ligase joined 3'-single base overhangs and 2-base overhangs effectively with little blunt or 5'- single base overhang activity; and human ligase 3 had highest activity on blunt ends and 5'-single base overhangs. There is no correlation of activity among ligases on blunt DNA ends with their activity on single base overhangs. In addition, DNA binding domains (Sso7d, hLig3 zinc finger, and T4 DNA ligase N-terminal domain) were fused to PBCV1 DNA ligase to explore whether modified binding to DNA would lead to greater activity on these difficult to ligate substrates. These engineered ligases showed both an increased binding affinity for DNA and increased activity, but did not alter the relative substrate preferences of PBCV1 DNA ligase, indicating active site structure plays a role in determining substrate preference.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • DNA Breaks, Double-Stranded
  • DNA Ligases / metabolism*
  • Electrophoresis, Capillary
  • Humans

Substances

  • DNA Ligases

Grants and funding

This project was funded internally by New England Biolabs, Inc. All authors were employees of New England Biolabs at the time the work was performed. Robert J. Bauer, Alexander Zhelkovsky, Katharina Bilotti, Thomas C. Evans, Jr., Larry A. McReynolds and Gregory J. S. Lohman are employees of New England Biolabs, a manufacturer and vendor of molecular biology reagents including DNA ligases. New England Biolabs funded the work and paid the salaries of all authors. Members of New England Biolabs not on the author list had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.